Ownership history in MARSHALL WACE, LLP · 5 quarters on record
This page tracks every 13F SEC filing in which MARSHALL WACE, LLP reported a position in CARTESIAN THERAP (RNAC). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 178,140 | +93,334 | +110.1% | 0.00% | $1.3M | $7.21 |
| 2025 Q3 | ADDED | 84,806 | +2,176 | +2.6% | 0.00% | $867K | $10.22 |
| 2025 Q2 | ADDED | 82,630 | +44,025 | +114.0% | 0.00% | $859K | $10.39 |
| 2025 Q1 | ADDED | 38,605 | +8,567 | +28.5% | 0.00% | $509K | $13.18 |
| 2024 Q2 | INITIATED | 30,038 | — | — | 0.00% | $811K | — |
As of 2025 Q4 — sorted by position size